Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
复制标题
DOI：
10.1016/s0140-6736(20)32259-5
复制
发表时间：
2020-11-21
期刊：
影响因子：
--
通讯作者：
WHO Ad Hoc Clinical Trial Expert Group
中科院分区：
文献类型：
--
作者：
Krause PR;Fleming TR;Ellenberg SS;Henao-Restrepo AM;WHO Ad Hoc Clinical Trial Expert Group
没有人质疑对安全有效的COVID-19疫苗的迫切需求。但疫苗开发过程中的保密性也至关重要。确保COVID-19疫苗的快速供应将取决于其安全性和有效性的严格证据。
No one disputes the urgent need for safe and effective COVID-19 vaccines. But confidentiality within the processes of vaccine development is also essential. Ensuring rapid availability of COVID-19 vaccines will depend on rigorous evidence of their safety and efficacy.